Yan Y, Newman A H, Xu M
Department of Anesthesia and Critical Care, The University of Chicago, Chicago, IL, USA.
Medicinal Chemistry Section, National Institute on Drug Abuse-Intramural Research Program, National Institutes of Health, Baltimore, MD, USA.
Neuroscience. 2014 Oct 10;278:154-64. doi: 10.1016/j.neuroscience.2014.08.008. Epub 2014 Aug 20.
Memories of drug experience and drug-associated environmental cues can elicit drug-seeking and taking behaviors in humans. Disruption of reconsolidation of drug memories dampens previous memories and therefore may provide a useful way to treat drug abuse. We and others previously demonstrated that dopamine D1 and D3 receptors play differential roles in acquiring cocaine-induced behaviors. Moreover, D3 receptors contribute to the reconsolidation of cocaine-induced conditioned place preference. In the present study, we examined effects of manipulating D1 or D3 receptors on reconsolidation of cocaine memories in mouse models of drug self-administration. We found that pharmacological blockade of D1 receptors or a genetic mutation of the D3 receptor gene attenuated reconsolidation that lasted for at least 1week after the memory retrieval. In contrast, with no memory retrieval, pharmacological antagonism of D1 receptors or the D3 receptor gene mutation did not significantly affect reconsolidation of cocaine memories. Pharmacological blockade of D3 receptors also attenuated reconsolidation in wild-type mice that lasted for at least 1week after the memory retrieval. These results suggest that D1 and D3 receptors and related signaling mechanisms play key roles in reconsolidation of cocaine memories in mice, and that these receptors may serve as novel targets for the treatment of cocaine abuse in humans.
对药物体验和与药物相关的环境线索的记忆能够引发人类的觅药和用药行为。破坏药物记忆的重新巩固会削弱先前的记忆,因此可能为治疗药物滥用提供一种有用的方法。我们和其他人之前证明,多巴胺D1和D3受体在获得可卡因诱导的行为中发挥不同作用。此外,D3受体有助于可卡因诱导的条件性位置偏好的重新巩固。在本研究中,我们在药物自我给药的小鼠模型中研究了操纵D1或D3受体对可卡因记忆重新巩固的影响。我们发现,D1受体的药理学阻断或D3受体基因的基因突变减弱了在记忆提取后持续至少1周的重新巩固。相比之下,在没有记忆提取的情况下,D1受体的药理学拮抗或D3受体基因突变对可卡因记忆的重新巩固没有显著影响。D3受体的药理学阻断也减弱了野生型小鼠在记忆提取后持续至少1周的重新巩固。这些结果表明,D1和D3受体以及相关的信号机制在小鼠可卡因记忆的重新巩固中起关键作用,并且这些受体可能成为治疗人类可卡因滥用的新靶点。